Join
Live feed
·
INSIDERFilingvia Quantisnow
Bluejay Diagnostics Inc. logo

President and CEO Dey Indranil was granted 28,000 shares, increasing direct ownership by 224% to 40,522 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
BJDX· Bluejay Diagnostics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BJDX (Bluejay Diagnostics Inc.) and more on Quantisnow.